In vitro cytotoxicity of chemoradiation with SN-38 in human colorectal cancer cells.

被引:0
|
作者
Balcer-Kubiczek, E [1 ]
Wood, A [1 ]
Kennedy, AS [1 ]
机构
[1] Univ Maryland, Baltimore, MD 21201 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
764
引用
收藏
页码:3807S / 3807S
页数:1
相关论文
共 50 条
  • [21] Combined efficacy and mechanism of trifluridine and SN-38 in a 5-FU-resistant human colorectal cancer cell lines
    Matsuoka, Kazuaki
    Takechi, Teiji
    AMERICAN JOURNAL OF CANCER RESEARCH, 2017, 7 (12): : 2577 - 2586
  • [22] Pregnane × Receptor (PXR) expression in colorectal cancer cells restricts irinotecan chemosensitivity through enhanced SN-38 glucuronidation
    Caroline Raynal
    Jean-Marc Pascussi
    Géraldine Leguelinel
    Cyril Breuker
    Jovana Kantar
    Benjamin Lallemant
    Sylvain Poujol
    Caroline Bonnans
    Dominique Joubert
    Frédéric Hollande
    Serge Lumbroso
    Jean-Paul Brouillet
    Alexandre Evrard
    Molecular Cancer, 9
  • [23] Synergistic cytotoxicity of cisplatin and topotecan or SN-38 in a panel of eight solid-tumor cell lines in vitro
    Jianguo Ma
    Marc Maliepaard
    Kees Nooter
    Antonius W. M. Boersma
    Jaap Verweij
    Gerrit Stoter
    Jan H. M. Schellens
    Cancer Chemotherapy and Pharmacology, 1998, 41 : 307 - 316
  • [24] A theranostic micelleplex co-delivering SN-38 and VEGF siRNA for colorectal cancer therapy
    Lee, Shin-Yu
    Yang, Chia-Ying
    Peng, Cheng-Liang
    Wei, Ming-Feng
    Chen, Ke-Cheng
    Yao, Cheng-Jung
    Shieh, Ming-Jium
    BIOMATERIALS, 2016, 86 : 92 - 105
  • [25] Synergistic cytotoxicity of cisplatin and topotecan or SN-38 in a panel of eight solid-tumor cell lines in vitro
    Ma, JG
    Maliepaard, M
    Notter, K
    Boersma, AWM
    Verweij, J
    Stoter, G
    Schellens, JHM
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1998, 41 (04) : 307 - 316
  • [26] Antagonistic Effects of CAPE (a Component of Propolis) on the Cytotoxicity and Genotoxicity of Irinotecan and SN38 in Human Gastrointestinal Cancer Cells In Vitro
    Gajek, Gabriela
    Marciniak, Beata
    Lewkowski, Jaroslaw
    Kontek, Renata
    MOLECULES, 2020, 25 (03):
  • [27] Combination of SN-38 with gefitinib or imatinib overcomes SN-38-resistant small-cell lung cancer cells
    Takigawa, Nagio
    Takeyama, Masami
    Kozuki, Toshiyuki
    Shibayama, Takuo
    Hisamoto, Akiko
    Kiura, Katsuyuki
    Tada, Atsuhiko
    Hotta, Katsuyuki
    Umemura, Shigeki
    Ohashi, Kadoaki
    Fujiwara, Yoshiro
    Takata, Saburo
    Ichihara, Eiki
    Osawa, Masahiro
    Tabata, Masahiro
    Tanimoto, Mitsune
    Takahashi, Kiyoshi
    ONCOLOGY REPORTS, 2007, 17 (05) : 983 - 987
  • [28] Breast cancer resistance protein directly confers SN-38 resistance of lung cancer cells
    Kawabata, S
    Oka, M
    Shiozawa, K
    Tsukamoto, K
    Nakatomi, K
    Soda, H
    Fukuda, M
    Ikegami, Y
    Sugahara, K
    Yamada, Y
    Kamihira, S
    Doyle, LA
    Ross, DD
    Kohno, S
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 280 (05) : 1216 - 1223
  • [29] Uptake mechanism of irinotecan (CPT-11) and its metabolite (SN-38) by hamster intestinal cells.
    Kobayashi, K
    Bouscarel, B
    Matsuzaki, Y
    Ceryak, S
    Fromm, H
    GASTROENTEROLOGY, 1998, 114 (04) : A626 - A627
  • [30] Pregnane x Receptor (PXR) expression in colorectal cancer cells restricts irinotecan chemosensitivity through enhanced SN-38 glucuronidation
    Raynal, Caroline
    Pascussi, Jean-Marc
    Legueline, Geraldine
    Breuker, Cyril
    Kantar, Jovana
    Lallemant, Benjamin
    Poujol, Sylvain
    Bonnans, Caroline
    Joubert, Dominique
    Hollande, Frederic
    Lumbroso, Serge
    Brouillet, Jean-Paul
    Evrard, Alexandre
    MOLECULAR CANCER, 2010, 9